Larvol Delta - ADCT301-in-Patients-With-RR-AML-MDS-or-MDSMPN

camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics

http://clinicaltrials.gov/ct2/show/NCT04639024

Jan 25, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next